Literature DB >> 28482512

Mechanistic study of in vitro chemical interaction of trimipramine drug with barbituric derivative after its oxidation: Electrochemical synthesis of new dibenzazepine derivative.

Shahram Lotfi1, Esmail Tammari2, Azizollah Nezhadali3.   

Abstract

Electrochemical oxidation of trimipramine in the absence and presence of 1,3 dimethyl barbituric acid as a nucleophile in aqueous solution has been studied using cyclic voltammetry and controlled-potential coulometry electrolysis. Voltammetric studies of electro-oxidation of trimipramine were realized in a range of pH1.0 to 8.0 in the absence and presence of 1,3 dimethyl barbituric acid. Based on the obtained electrochemical results, dimerization is the main reaction of electro-oxidation of trimipramine in the absence of nucleophile. The voltammetric data indicate that the 1,3 dimethyl barbituric acid participation in Michael addition reaction with the oxidized dimeric form of trimipramine via an ECEC electrochemical mechanisms. On the other hand the results indicate existence of a catalytic (EC') electrochemical mechanism in parallel with ECEC electrochemical mechanism. This method provides a facile and one-pot procedure for the synthesis of new dibenzazepine derivative. Finally, a possible mechanism is proposed for the electrode process, on the basis of the present and previous investigations. The product has been characterized by IR, 1H NMR, 13CNMR and MS methods.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  1,3 Dimethyl barbituric acid (DMBA); Cyclic voltammetry; Dibenzazepine derivative; Electrochemical mechanism; Trimipramine (TMP)

Mesh:

Substances:

Year:  2017        PMID: 28482512     DOI: 10.1016/j.msec.2017.03.022

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  1 in total

1.  A green protocol for the electrochemical synthesis of a fluorescent dye with antibacterial activity from imipramine oxidation.

Authors:  Zahra Souri; Mahmood Masoudi Khoram; Davood Nematollahi; Mohammad Mazloum-Ardakani; Hojjat Alizadeh
Journal:  Sci Rep       Date:  2022-03-22       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.